Prognostic significance of ferroptosis pathway gene signature and correlation with macrophage infiltration in cervical squamous cell carcinoma

International Immunopharmacology - Tập 112 - Trang 109273 - 2022
Chia-Jung Li1,2, Chiung-Hung Chang3, Yi-Ling Tsang4, Shao-Hsuan Fang1, San-Nung Chen1, An-Jen Chiang1,5
1Department of Obstetrics and Gynecology, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan
2Institute of BioPharmaceutical Sciences, National Sun Yat-sen University, Kaohsiung 804, Taiwan
3Department of Traditional Chinese Medicine, Tainan Municipal Hospital, Tainan 701, Taiwan
4Institute of Physiological Chemistry and Pathobiochemistry and Cells in Motion Interfaculty Centre (CiMIC), University of Münster, Münster, Germany
5Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan

Tài liệu tham khảo

El Awady, 1987, Molecular analysis of integrated human papillomavirus 16 sequences in the cervical cancer cell line SiHa, Virology, 159, 389, 10.1016/0042-6822(87)90478-8 Herengt, 2021, NRF2 in viral infection, Antioxidants (Basel), 10, 1491, 10.3390/antiox10091491 Hayes, 2014, The Nrf2 regulatory network provides an interface between redox and intermediary metabolism, Trends Biochem. Sci., 39, 199, 10.1016/j.tibs.2014.02.002 Ramesh, 2020, NRF2, p53, and p16: Predictive biomarkers to stratify human papillomavirus associated head and neck cancer patients for de-escalation of cancer therapy, Crit. Rev. Oncol. Hematol., 148, 10.1016/j.critrevonc.2020.102885 T. K, Y. M, The KEAP1-NRF2 system in cancer, Front. Oncol. 7 (2017). Z. C, T. ZK, F. IH, Papillomavirus immune evasion strategies target the infected cell and the local immune system, Front. Oncol. 9 (2019). Burgers, 2007, Viral oncoproteins target the DNA methyltransferases, Oncogene, 26, 1650, 10.1038/sj.onc.1209950 Ns, 2018, Vorinostat, a pan-HDAC inhibitor, abrogates productive HPV-18 DNA amplification, PNAS, 115 Li, 2021, Identification of novel biomarkers and candidate drug in ovarian cancer, J. Pers. Med., 11, 316, 10.3390/jpm11040316 J.Y. Li, C.J. Li, L.T. Lin, K.H. Tsui, Multi-omics analysis identifying key biomarkers in ovarian cancer, Cancer Control 27 (1) (2020), doi: 1073274820976671. Chu, 2022, Downregulation of ATP binding cassette subfamily a member 10 acts as a prognostic factor associated with immune infiltration in breast cancer, Aging (Albany NY), 14, 2252, 10.18632/aging.203933 Li, 2021, Acetyl coenzyme A synthase 2 acts as a prognostic biomarker associated with immune infiltration in cervical squamous cell carcinoma, Cancers (Basel), 13, 3125, 10.3390/cancers13133125 Tang, 2017, GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses, Nucleic Acids Res., 45, W98, 10.1093/nar/gkx247 Lee, 2021, Q-omics: smart software for assisting oncology and cancer research, Mol. Cells, 44, 843, 10.14348/molcells.2021.0169 Li, 2020, A novel biomarker driving poor-prognosis liver cancer: overexpression of the mitochondrial calcium gatekeepers, Biomedicines, 8, 451, 10.3390/biomedicines8110451 Tzeng, 2022, Integrated analysis of pivotal biomarker of LSM1, immune cell infiltration and therapeutic drugs in breast cancer, J Cell Mol Med, 26, 4007, 10.1111/jcmm.17436 Sun, 2016, Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells, Hepatology, 63, 173, 10.1002/hep.28251 Sun, 2016, Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis, Hepatology, 64, 488, 10.1002/hep.28574 Czogalla, 2018, Interaction of ERalpha and NRF2 impacts survival in ovarian cancer patients, Int. J. Mol. Sci., 20, 10.3390/ijms20010112 Czogalla, 2019, Correlation of NRF2 and progesterone receptor and its effects on ovarian cancer biology, Cancer Manag. Res., 11, 7673, 10.2147/CMAR.S210004 Gorrini, 2013, BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival, J. Exp. Med., 210, 1529, 10.1084/jem.20121337 Long, 2000, NAD(P)H:quinone oxidoreductase 1 deficiency increases susceptibility to benzo(a)pyrene-induced mouse skin carcinogenesis, Cancer Res., 60, 5913 Ramos-Gomez, 2001, Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice, Proc. Natl. Acad. Sci. U. S. A., 98, 3410, 10.1073/pnas.051618798 A.C. Nicholson, M. Febbraio, J. Han, R.L. Silverstein, D.P. Hajjar, CD36 in atherosclerosis. The role of a class B macrophage scavenger receptor, Ann. N. Y. Acad. Sci. 902 (2000) 128–131; discussion 131-3. Ishii, 2004, Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal, Circ. Res., 94, 609, 10.1161/01.RES.0000119171.44657.45 Yoshida, 1998, Minimally oxidized low-density lipoprotein increases expression of scavenger receptor A, CD36, and macrosialin in resident mouse peritoneal macrophages, Arterioscler Thromb. Vasc. Biol., 18, 794, 10.1161/01.ATV.18.5.794 Barajas, 2011, NF-E2-related factor 2 promotes atherosclerosis by effects on plasma lipoproteins and cholesterol transport that overshadow antioxidant protection, Arterioscler Thromb Vasc. Biol., 31, 58, 10.1161/ATVBAHA.110.210906 Sussan, 2008, Disruption of Nrf2, a key inducer of antioxidant defenses, attenuates ApoE-mediated atherosclerosis in mice, PLoS ONE, 3, e3791, 10.1371/journal.pone.0003791 Takabe, 2011, Anti-atherogenic effect of laminar shear stress via Nrf2 activation, Antioxid Redox Signal, 15, 1415, 10.1089/ars.2010.3433 Zhao, 2015, Cleaning up after ICH: the role of Nrf2 in modulating microglia function and hematoma clearance, J. Neurochem., 133, 144, 10.1111/jnc.12974 DeNicola, 2011, Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis, Nature, 475, 106, 10.1038/nature10189 Ganan-Gomez, 2013, Oncogenic functions of the transcription factor Nrf2, Free Radic. Biol. Med, 65, 750, 10.1016/j.freeradbiomed.2013.06.041 Menegon, 2016, The dual roles of NRF2 in cancer, Trends Mol. Med., 22, 578, 10.1016/j.molmed.2016.05.002 Rojo de la Vega, 2018, NRF2 and the hallmarks of cancer, Cancer Cell, 34, 21, 10.1016/j.ccell.2018.03.022